Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
505400
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of paid stock options (stock acquisition rights) (TriEyes Co., Ltd. 18th Series Stock Acquisition Rights)
Who receives how much
505,400 shares (5,054 stock acquisition rights, 100 shares per right)
2 of the Company's directors, excluding directors who are Audit and Supervisory Committee members505,400 shares
The lower thin line represents the existing number of shares to which these shares will be added.
¥20 per stock acquisition right (¥0.2 per underlying share)
Total issue value
¥101,080 (¥20 × 5,054 rights)
Amount of funds to be raised
Total amount to be paid for the stock acquisition rights: ¥101,080. Estimated net proceeds: Not disclosed.
Terms of the stock acquisition rights
Exercise price
The initial exercise price is ¥835 per share. If certain events occur, it will be adjusted according to the prescribed adjustment formula. The minimum exercise price is Not disclosed.
Exercise period
From 1 June 2026 to 30 May 2031 (or until the immediately preceding bank business day if the final day is a bank holiday)
Number of Stock Acquisition Rights
Total number issued: 5,054 rights. Number of outstanding unexercised rights: Not disclosed.
Reason for acquisition without consideration
If a stock acquisition rights holder ceases to hold the position of director, Audit & Supervisory Board member, or employee, or otherwise ceases to satisfy the exercise conditions or becomes unable to exercise the rights. This also applies if achievement of the performance targets becomes impossible. If certain proposals relating to a corporate reorganization or other matters are approved, the Company may acquire the rights at an acquisition price equal to the amount paid for them.
Categories and Number of Persons Covered
2 of the Company's directors, excluding directors who are Audit and Supervisory Committee members, totaling 5,054 rights and 505,400 shares. The breakdown by individual is Not disclosed.
Payment date
29 May 2026
Basis for determining the amount to be paid
The issue price is equal to the valuation calculated by 株式会社赤坂国際会計, an independent valuation institution, using a Monte Carlo simulation based on the Company's share price information and other factors. The discount or premium to the closing price and average share price is Not disclosed.
Impact on Business Performance
The Company expects the issuance of these stock acquisition rights to have a minor impact on consolidated results for the current fiscal year.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of paid stock options (stock acquisition rights) (TriEyes Co., Ltd. 18th Series Stock Acquisition Rights) |
| Number of shares to be issued or disposed of | 505,400 shares (5,054 stock acquisition rights, 100 shares per right) |
| Issue price and disposal price | ¥20 per stock acquisition right (¥0.2 per underlying share) |
| Total issue value | ¥101,080 (¥20 × 5,054 rights) |
| Amount of funds to be raised | Total amount to be paid for the stock acquisition rights: ¥101,080. Estimated net proceeds: Not disclosed. |
| Payment date | 29 May 2026 |
| Intended allottee | Category 2 of the Company's directors, excluding directors who are Audit and Supervisory Committee members / Number of Shares 505,400 shares / Number of stock acquisition rights 5,054 stock acquisition rights |
| Basis for determining the amount to be paid | The issue price is equal to the valuation calculated by 株式会社赤坂国際会計, an independent valuation institution, using a Monte Carlo simulation based on the Company's share price information and other factors. The discount or premium to the closing price and average share price is Not disclosed. |
| Exercise price | The initial exercise price is ¥835 per share. If certain events occur, it will be adjusted according to the prescribed adjustment formula. The minimum exercise price is Not disclosed. |
| Exercise period | From 1 June 2026 to 30 May 2031 (or until the immediately preceding bank business day if the final day is a bank holiday) |
| Number of Stock Acquisition Rights | Total number issued: 5,054 rights. Number of outstanding unexercised rights: Not disclosed. |
| Reason for acquisition without consideration | If a stock acquisition rights holder ceases to hold the position of director, Audit & Supervisory Board member, or employee, or otherwise ceases to satisfy the exercise conditions or becomes unable to exercise the rights. This also applies if achievement of the performance targets becomes impossible. If certain proposals relating to a corporate reorganization or other matters are approved, the Company may acquire the rights at an acquisition price equal to the amount paid for them. |
| Categories and Number of Persons Covered | 2 of the Company's directors, excluding directors who are Audit and Supervisory Committee members, totaling 5,054 rights and 505,400 shares. The breakdown by individual is Not disclosed. |
| Impact on Business Performance | The Company expects the issuance of these stock acquisition rights to have a minor impact on consolidated results for the current fiscal year. |
Items this document does not state (14)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To encourage the directors to share value with shareholders and strengthen their commitment to expanding business performance, improving profitability, providing ongoing shareholder returns, and enhancing the Company's valuation in the stock market. In addition, requiring the eligible recipients to acquire the rights for consideration is intended to clarify their sense of responsibility for achieving performance targets and enhancing shareholder value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.